Compare HUBB & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUBB | BNTX |
|---|---|---|
| Founded | 1888 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 24.8B |
| IPO Year | N/A | 2019 |
| Metric | HUBB | BNTX |
|---|---|---|
| Price | $455.96 | $94.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $488.43 | $137.40 |
| AVG Volume (30 Days) | 479.0K | ★ 1.6M |
| Earning Date | 02-03-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | ★ 15.10 | N/A |
| EPS | ★ 15.99 | N/A |
| Revenue | ★ $5,686,200,000.00 | $3,698,814,972.00 |
| Revenue This Year | $5.89 | $2.03 |
| Revenue Next Year | $7.65 | N/A |
| P/E Ratio | $28.52 | ★ N/A |
| Revenue Growth | 0.82 | ★ 3.70 |
| 52 Week Low | $299.43 | $81.20 |
| 52 Week High | $484.26 | $129.27 |
| Indicator | HUBB | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.21 | 42.08 |
| Support Level | $424.69 | $91.32 |
| Resistance Level | $466.67 | $93.76 |
| Average True Range (ATR) | 11.56 | 2.16 |
| MACD | 1.44 | -0.04 |
| Stochastic Oscillator | 74.46 | 34.20 |
Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.